Get startedLog in
    Picture of Pentixapharm Holding AG logo

    PTP — Pentixapharm Holding AG Income Statement

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Pentixapharm Holding AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

    2010
    December 31st
    R2024
    December 31st
    2025
    December 31st
    Period Length:52 W41 W12 M
    Source:ARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinal
    Revenue
    Total Revenue—6.820.093
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Operating Interest Expense / Income
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses—23.820
    Operating Profit—-17-19.9
    Total Net Non Operating Interest Income / Expense
    Total Net Non Operating Interest Income / Expense
    Net Income Before Taxes—-16.6-19.5
    Provision for Income Taxes
    Net Income After Taxes—-11.9-16.5
    Net Income Before Extraordinary Items
    Net Income—-11.9-16.5
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income—-11.9-16.5
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS—0.169-0.609
    Dividends per Share